Lidocaine is a widely used local anesthetic and antiarrhythmic drug th
at is believed to exert its clinically important action by blocking vo
ltage-gated Na+ channels. Studies of Na+ channels from different speci
es and tissues and the complexity of the drug-channel interaction crea
te difficulty in understanding whether there are Na+ channel isoform s
pecific differences in the affinity for lidocaine. Clinical usage sugg
ests that lidocaine selectively targets cardiac Na+ channels because i
t is effective for the treatment of arrhythmias with few side effects
on muscle or neuronal channels except at higher concentrations. One po
ssibility for this selectivity is an intrinsically higher drug-binding
affinity of the cardiac isoform. Alternatively, lidocaine may appear
cardioselective because of preferential interactions with the inactiva
ted state of the Na+ channel, which is occupied much longer in cardiac
cells. Recombinant skeletal muscle (hSkM1) and cardiac sodium channel
s (hH1) were studied under identical conditions, with a whole-cell vol
tage clamp used to distinguish the mechanisms of lidocaine block. Toni
c block at high concentrations of lidocaine (0.1 mM) was greater in hH
1 than in hSkM1. This was also true for use-dependent block, for which
25-mu M lidocaine produced an inhibition in hH1 equivalent to 0.1 mM
in the skeletal muscle isoform. Pulse protocols optimized to explore i
nactivated-state block revealed that hSkM1 was five to eight times les
s sensitive to block by lidocaine than was hH1. The results also indic
ate that relatively more open-state block occurs in hSkM1. Thus, the c
ardiac sodium channel is intrinsically more sensitive to inhibition by
lidocaine.